Abstract

LyophilizationLyophilization (or freezeFreeze/thaw drying) is an important manufacturing capability for delivering high-quality parenteral drugDrug/device combination products products. Significant lyophilizationLyophilization process knowledge based on established scientific fundamentals and understanding of the good freezeFreeze/thaw drying practice principles exists within the pharmaceutical industry. This cumulative scientific knowledge should be leveraged across the portfolio of both small and large molecules and serves as the basis to gain process and product understanding. By using the scientific principles of lyophilizationLyophilization , good freezeFreeze/thaw drying practices and existing product knowledge, a risk-based approach to process developmentProcess development will facilitate focused efforts to increase product and process understanding to decrease those risks and identify which parameters are critical for product quality. Ultimately, this approach driven by scientific principles results in the developmentDevelopment of a robust control strategyControl strategy for a given product. The process whereby this occurs is based on principles of Quality by Design (QbD)Quality by design (QbD) as defined in ICH Q8 (R2) Pharmaceutical DevelopmentDevelopment . This chapter brings together the technical knowledge of the lyophilizationLyophilization process, well-established scientific lyophilizationLyophilization principles and elements of QbDQuality by design (QbD) to provide guidance on approaches to develop a robust manufacturing process and support a regulatory filing strategy for drugDrug/device combination products products, while maximizing the freedom to operate. While it incorporates QbDQuality by design (QbD) elements that align with ICH Q8 (R2), Q9, Q10, and Q11, the goal is to define a knowledge space based on robust scientific evidence and principles. Having this knowledge and data will provide the basis to justify the control strategyControl strategy and lyophilizationLyophilization process description in the dossier that presents the critical product quality attributes and a process control strategyControl strategy that is defined by the critical process parameters to ensure consistent product quality.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.